As expected, MECP2 E1 and E2 isoforms and IRAK1 mRNA levels in blood were significantly higher in MDS patients than in control individuals (p = 0.026, p = 0.023 and p = 0.012, respectively), as both genes are duplicated in MDS. This evidence concerns the gene MECP2 and myelodysplastic syndrome.